Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977215 | Brachytherapy | 2014 | 8 Pages |
Abstract
The clinical data show that NBT in combination with EBRT produced favorable local control and long-term survival rates for patients with esophageal cancer and that the side effects are tolerable. As such, we conclude that this dual-modality method is an effective and safe way for treating esophageal cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Huiming Liu, Qifeng Wang, Xin Wan, Xitang Jia, Bo Liu, C-K Chris Wang,